Bromday Versus Nevanac Eye Drops to Control Pain Following Photorefractive Keratectomy

Bromday (Bromfenac Ophthalmic Solution)0.09% QD vs Nevanac (Nepafenac Ophthalmic Suspension) 0.1% TID for Control of Pain and Epithelial Healing Post (PRK)

This study will compare the effect of two topical non-steroidal antiinflammatory agents to control pain after photorefractive keratectomy (PRK) eye surgery.

Inclusion Criteria:

• male or female at least 18 years of age,
• no other ocular studies with 15 days prior to dosing,
• BCVA 20/200 or better,
• return for study visits and follow instructions from investigator and staff,
• self administer test article

Exclusion Criteria:

• Ocular inflammation,
• hypersensitivity to bromfenac or nepafenac,
• any corneal pathology,
• have had radial keratotomy,
• corneal transplant or corneal refractive surgery in the last two years